Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Carbamate derivatives of short-acting bronchodilator albuterol inhibits human acetylcholinesterase and butyrylcholinesterase (CROSBI ID 661833)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Bosak, Anita ; Knežević, Anamarija ; Zlatić, Katarina ; Kerep, Robert ; Kovarik, Zrinka Carbamate derivatives of short-acting bronchodilator albuterol inhibits human acetylcholinesterase and butyrylcholinesterase // Book of Abstracts of the 10th Congress of Toxicology in Developing Countries and 12th Congress of the serbian Society of Toxicology. 2018. str. 114-114

Podaci o odgovornosti

Bosak, Anita ; Knežević, Anamarija ; Zlatić, Katarina ; Kerep, Robert ; Kovarik, Zrinka

engleski

Carbamate derivatives of short-acting bronchodilator albuterol inhibits human acetylcholinesterase and butyrylcholinesterase

Novel synthesised biscarbamate and monocarbamate derivatives of the short-acting bronchodilator albuterol (biscalb) resemble the structure of biscarbamate bambuterol, whose bioconversion to the bronchodilator terbutaline in an organism is enabled through the inhibition of butyrylcholinesterase (BChE). Bambuterol’s high therapeutic index is associated with an extremely selective BChE inhibition compared to acetylcholinesterase (AChE). We determined the inhibition potency of biscalb and monocalb toward human BChE and AChE to evaluate their selectivity. Both carbamates proved to be potent inhibitors of both cholinesterases with ki constants within 103-105 M-1min-1. Biscalb and monocalb inhibited AChE only 10 times slower than they did BChE, meaning that the selectivity of both carbamates was very poor compared to the 20, 000 times faster inhibition of BChE determined for bambuterol. Therefore, the novel compounds lack potential for prodrug development in analogy with bambuterol. However, due to their inhibition potency, these novel carbamates could be considered structural and functional lead compounds for the design of new compounds, whose primary action would be inhibition of cholinesterases, like pesticides or neurodegenerative disease drugs. Supported by CSF Grant no. 4307.

cholinesterase, selectivity, monocarbamate, biscarbamate, prodrug

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

114-114.

2018.

objavljeno

Podaci o matičnoj publikaciji

Book of Abstracts of the 10th Congress of Toxicology in Developing Countries and 12th Congress of the serbian Society of Toxicology

Podaci o skupu

10th Congress of Toxicology in Developing Countries (CTDC 10) ; 12th Serbian Congress of Toxicology

poster

18.04.2018-21.04.2018

Beograd, Srbija

Povezanost rada

nije evidentirano